Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine

202061 citationsJournal Article

Authors

NCT02873286.

Good health and well-being

Published in: The Journal of Infectious Diseases

Volume 223, Issue 6, pp. 1062-1072

Field-Weighted Citation Impact: 5.67